Crunchbase News

JANUARY 6, 2025

Although 2024 was another exceptionally lackluster year for new public offerings, the IPO market could gain momentum in 2025 after its three-year lull. With that in mind, here are 13 companies that the Crunchbase News team thinks could be top contenders to go public if our 2025 market forecast bears out. That made sense.

Marketing 129

Marketing Company Technical Review Fintech 129

N2Growth Blog

OCTOBER 23, 2023

Additionally, the industry’s highly regulated nature means that executives must have a keen eye for compliance and a strong ability to navigate the ever-changing market dynamics. Top executive search firms also bring a unique set of resources and expertise to the table when it comes to attracting top talent for biotech companies.

Biotech 178

Biotech Strategy Artificial Inteligence Recruiting 178

Crunchbase News

JANUARY 7, 2025

Close to a third of all global venture funding went to companies in AI-related fields, making artificial intelligence the leading sector for funding. funding market raised a greater proportion of global funding, up from 48% in 2023. Large early-stage rounds went to data centers, renewable energy, AI, robotics and biotech.

Artificial Intelligence 144

Artificial Intelligence Artificial Inteligence Report Technical Review 144

Crunchbase News

NOVEMBER 22, 2024

xAI , $5B, artificial intelligence: Generative AI startup xAI raised $5 billion in a funding round valuing it at $50 billion, The Wall Street Journal reported. Anthropic , $4B, artificial intelligence: Amazon has agreed to invest another $4 billion in AI startup Anthropic — a ChatGPT rival with its AI assistant Claude.

Artificial Intelligence 122

Artificial Intelligence Artificial Inteligence Biotech Generative AI 122

TechCrunch

JUNE 6, 2022

Insilico Medicine, a Hong Kong-based company that has been using artificial intelligence to discover new drugs since 2014, has completed a fresh round of funding. “Right now the market is in ‘biotechnology winter’ where many companies are running out of cash and are dying.

Biotech 211

Biotech Artificial Intelligence Artificial Inteligence Pharmaceuticals 211

TechCrunch

MARCH 17, 2023

Best practices for leveraging artificial intelligence and machine learning in 2023 Zero-based budgeting: A proven framework for extending runway Image Credits: Getty Images It’s critical to make every dollar count in this environment, but pulling back too much in the wrong places can reduce momentum across your entire organization. “The

Budget 230

Budget Biotech Artificial Inteligence Banking 230

TechCrunch

MAY 31, 2022

The appetite for genomic data continues to rise in the field of biotech and pharmaceutical research, but cost is still a factor — even sequencing a full genome now costs as little as $1,000. This could push the price lower, but for now a 90% reduction is more than enough to go to market with.

Biotech 315

Biotech Pharmaceuticals Study Artificial Inteligence 315

TechCrunch

APRIL 6, 2022

Navigating the choppy e-commerce seas : As reporter Ingrid Lunden writes, “e-commerce is synonymous with shopping on Amazon, but the reality is that a retailer has the option to use a bundle of different channels to sell and market products.” 6 questions investors should ask when evaluating psychedelic biotech companies. Big Tech Inc.

Marketing 235

Marketing Biotech Retail 3D 235

Crunchbase News

DECEMBER 15, 2023

The week was especially good for biotech, which led the way with two big raises. Tome Biosciences , $213M, biotech: A big biotech raise hit high on the list this week. Bicara Therapeutics , $165M, biotech: If Bicara Therapeutics looks familiar, it’s because this isn’t its first time on this list.

Biotech 122

Biotech Artificial Intelligence Artificial Inteligence Hotels 122

Crunchbase News

FEBRUARY 28, 2025

Not surprisingly, those two rounds came from the cybersecurity and biotech industries. Eikon Therapeutics , $351M, biotech: Eikon Therapeutics raised one of the biggest biotech rounds thus far in this young year. Founded in 2023, the company has raised $77 million, per Crunchbase.

Biotech 75

Biotech Artificial Intelligence Artificial Inteligence Healthcare 75

TechCrunch

DECEMBER 2, 2020

Sifting through the trillions of molecules out there that might have powerful medicinal effects is a daunting task, but the solution biotech has found is to work smarter, not harder. We will be hiring more top notch AI researchers, software engineers, medicinal chemists and biotech talent, as well as building our own research labs.”

Biotech 265

Biotech 3D Artificial Inteligence Machine Learning 265

Crunchbase News

AUGUST 9, 2024

billion — the highest amount invested at this stage in two years — that increase was concentrated in larger fundings and in two leading sectors — healthcare/biotech and AI. As the market tightened, seed-stage companies faced a more challenging environment in which to raise a Series A round. While total funding reached $31.5

Biotech 136

Biotech Artificial Intelligence Artificial Inteligence Healthcare 136

Crunchbase News

OCTOBER 1, 2024

However, it wasn’t just AI that got funding in September, as biotech makes up about half the list. Safe Superintelligence , $1B, artificial intelligence: AI research lab Safe Superintelligence raised $1 billion from a litany of big-name investors including Andreessen Horowitz and Sequoia Capital.

Biotech 120

Biotech Artificial Intelligence Artificial Inteligence Travel 120

TechCrunch

MAY 26, 2021

So a new crop of biotech companies have worked to integrate these aspects. The money will go toward the requisite testing and paperwork involved in bringing a new drug to market based on promising leads. 2021 should be a banner year for biotech startups that make smart choices early.

Engineering 248

Engineering Biotech Chemicals Artificial Inteligence 248

Crunchbase News

JUNE 27, 2024

For the past few years the M&A market for startups has been slow — and the IPO pipeline nonexistent. However, just as AI is taking over venture, perhaps it is doing that for the M&A and IPO markets. Last week, artificial intelligence chips startup Cerebras Systems reportedly filed confidentially for an initial public offering.

Marketing 127

Marketing Artificial Intelligence Artificial Inteligence Biotech 127

Crunchbase News

SEPTEMBER 13, 2024

Biotech and AI had another strong week, as the sectors saw two big nine-figure rounds each — including one for $370 million in biotech. Candid Therapeutics , $370M, biotech: Every week there’s a big biotech raise — and this week there’s one that’s really big. Check out last week’s biggest funding rounds here.

Biotech 77

Biotech Artificial Inteligence Artificial Intelligence Healthcare 77

Crunchbase News

JUNE 7, 2024

Pika , $80M, artificial intelligence: It never takes us long to get to an AI startup on this list. Pika, an artificial intelligence startup that generates video, raised an $80 million round led by Spark Capital that values the Palo Alto, California-based company at $470 million, per Bloomberg.

Energy 126

Energy Biotech 3D Artificial Intelligence 126

Crunchbase News

JUNE 14, 2024

AI, biotech, space tech and cybersecurity also saw good-sized raises. Clearly GM is betting — big — the autonomous driving and robotaxi market comes back. The New York-based startup’s market intelligence and search platform — powered by AI and natural language processing — helps clients form corporate and investment strategies.

Biotech 129

Biotech Technical Review Artificial Intelligence Artificial Inteligence 129

TechCrunch

SEPTEMBER 28, 2021

In an increasingly hot biotech market, protecting IP is key. Lifebit says it has a patented technology for federating the data around genomic data, allowing researchers to get more insights while keeping the data secure. Privacy issues are regularly raised around genomic data.

Biotech 248

Biotech Data Government Research 248

N2Growth Blog

JANUARY 10, 2024

The life sciences industry is characterized by unique challenges and complexities, requiring leaders who deeply understand scientific advancements, regulatory frameworks, and highly dynamic market conditions.

Biotech 97

Biotech Leadership Recruiting Trends 97

TechCrunch

APRIL 23, 2021

A biotech company that has spent 11 years researching supplements to increase human longevity plans to launch its supplements later this year. How and when to build marketing teams at deep tech companies. Longevica says it created a biotechnology platform for longevity after researching the life-span of laboratory mice.

Research 261

Research Biotech Nonprofit Comparison 261

Crunchbase News

MARCH 29, 2024

While there were no huge rounds like last week, money was again spread around from AI to biotech to marketing and more. tied) The Brandtech Group , $115M, marketing : It seems like every week there is a big funding round involving the intersection of AI and some new sector.

Biotech 129

Biotech Artificial Intelligence Artificial Inteligence Energy 129

Crunchbase News

JULY 12, 2024

After a quiet holiday week, investors were back in action dishing out big rounds to startups in robotics, biotech, healthcare and more. Element Biosciences , $277M, biotech: It’s hard to get through a week without a big biotech raise, and this one’s no different. based companies? Check out The Crunchbase Megadeals Board.

Biotech 121

Biotech Artificial Intelligence Artificial Inteligence Healthcare 121

Crunchbase News

FEBRUARY 16, 2024

Not exactly sure what was in the water this week, but AI and biotech led the way as happens often. Lambda , $320M, artificial intelligence: In a big week, this was the biggest round. The company offers cloud computing services and hardware for training artificial intelligence software. billion valuation.

Lambda 125

Lambda Biotech Artificial Intelligence Artificial Inteligence 125

TechCrunch

MARCH 16, 2023

Charge it : Parker is taking on the world of corporate cards — and trying to grab a piece of the market from companies like Brex and Ramp — with its new credit offering tailored to the needs of e-commerce brands. Staying power : 5 strategies for biotech startups to outlast a market downturn , as advised by James Coates.

Banking 249

Banking Biotech Report Artificial Intelligence 249

Crunchbase News

JULY 10, 2024

North American startup funding perked up in the second quarter, bolstered by early-stage investment around artificial intelligence. Artificial intelligence remains the runaway favorite investment theme, as AI-focused startups pulled in $16.8 Overall, investors put $45.3 and Canadian startups in the second quarter of 2024.

Biotech 140

Biotech Artificial Intelligence Artificial Inteligence Report 140

Crunchbase News

OCTOBER 4, 2024

The past quarter was a quirky one for North America startup funding, with a slowdown in some pockets counterbalanced by continued high enthusiasm around artificial intelligence, Crunchbase data shows. While the IPO market wasn’t especially active, we did see a handful of public offerings, predominantly in the biotech sector.

Biotech 129

Biotech Technical Review Artificial Intelligence Artificial Inteligence 129

Crunchbase News

AUGUST 2, 2024

Outpace Bio , $144M, biotech: The big biotech raise of the week came from Outpace Bio. The biotech uses AI-powered protein design to program immune cells battling tumors. The company also uses artificial intelligence to help members get care faster. The new round was led by Aliment Capital.

Biotech 124

Biotech Artificial Inteligence Artificial Intelligence Insurance 124

CIO

NOVEMBER 25, 2024

These transformational programs, from reporting to BI to having cohesive sales and marketing teams to ERP, include everyone, not just IT. I’ve had many great positions throughout my career, in many different industries, from biotech to pharma to tech software companies, and currently at a medical device company. Then I started working.

Company 183

Company Technical Advisors Engineering Biotech 183

CIO

MAY 15, 2024

The biotech company Moderna , for example, is aiming to use ChatGPT Enterprise to “automate nearly every business process” in order to “outpace its plan to roll out 15 new products within the next five years.” And with every passing day, “your guess is as good as mine” will become an increasingly uncomfortable answer.

Artificial Inteligence 195

Artificial Inteligence Generative AI Biotech Artificial Intelligence 195

N2Growth Blog

DECEMBER 12, 2024

At N2Growth, we approach the healthcare leadership market with a nuanced lens, drawing on decades of industry experience to ensure that leaders possess the necessary technical expertise and the resilience, strategic insight, and emotional intelligence essential for inspiring teams and shaping the future of patient care.

Healthcare 78

Healthcare Technical Review Leadership Sustainability 78

Crunchbase News

DECEMBER 20, 2024

After another slow year in 2024 for new tech listings, there is an expectation that the IPO markets will pick up in 2025. I think there’s a lot of confidence in the market. Stock markets are trading at all-time highs, said Ran Ben-Tzur of legal advisory firm Fenwick & West. A year ago, the outlook was not bullish.

Fintech 133

Fintech Marketing Small Business Windows 133

Crunchbase News

APRIL 19, 2024

Metsera , $290M, biotech: This week was a slower week than normal for biotech — as it was for most sectors — but that didn’t stop New York-based Metsera. The company develops power-optimized chips targeting the data analytics and generative AI markets. In fact, it only took raising about $30 million-plus to make the list.

Biotech 122

Biotech Generative AI Artificial Intelligence Artificial Inteligence 122

Crunchbase News

OCTOBER 18, 2024

Terray Therapeutics , $120M, biotech: Los Angeles-based Terray Therapeutics, a biotech startup developing small molecule drug therapeutics, raised a $120 million Series B led by new investor Bedford Ridge Capital and existing investor NVentures. Founded in 2021, the company has raised nearly $318 million, per Crunchbase.

Energy 114

Energy Artificial Inteligence Artificial Intelligence Biotech 114

Crunchbase News

JUNE 28, 2024

Formation Bio , $372M, biotech: Every week there is a big biotech raise and this week’s is really big. More and more biotech startups are using AI to help with their drug processes and investors are clearly taking note. Sidecar Health believes a free-market approach will ensure healthcare is more accessible and affordable.

Artificial Inteligence 116

Artificial Inteligence Biotech Generative AI Healthcare 116

Crunchbase News

JULY 2, 2024

Clearly GM is betting — big — the autonomous driving and robotaxi market comes back. AlphaSense , $650M, artificial intelligence: AI-driven market intelligence platform AlphaSense raised $650 million in funding co-led by Viking Global Investors and BDT & MSD Partners at a $4 billion valuation — a 75% increase from just nine months ago.

Artificial Inteligence 127

Artificial Inteligence Biotech Software Review Healthcare 127

Crunchbase News

MAY 2, 2024

April also saw a half-dozen rounds of a quarter-billion dollars or more, including a $1 billion round for an AI-enhanced biotech. Xaira Therapeutics , $1B, biotech: The biggest round in April was really big. The company develops power-optimized chips targeting the data analytics and generative AI markets. Let’s take a look.

Biotech 126

Biotech Blockchain Generative AI Energy 126